Rossari Biotech fixes record date for FY26 dividend of Re. 0.50

1 min read     Updated on 29 Jun 2026, 08:55 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Rossari Biotech has announced Friday, July 10, 2026, as the record date for a final dividend of Re. 0.50 per equity share for the financial year ended March 31, 2026. The dividend is subject to shareholder approval at the 17th Annual General Meeting scheduled for Monday, July 20, 2026, via video conferencing. Remote e-voting will be open from July 17 to July 19, 2026.

powered bylight_fuzz_icon
43326057

*this image is generated using AI for illustrative purposes only.

Rossari Biotech has fixed Friday, July 10, 2026, as the record date to determine member eligibility for a final dividend of Re. 0.50 (25%) per equity share for the financial year ended March 31, 2026. The dividend is subject to shareholder approval at the upcoming Annual General Meeting (AGM). If approved, the payout will be made within 10 working days from the conclusion of the AGM, subject to tax deduction at source.

The company has scheduled its 17th AGM for Monday, July 20, 2026, at 11:00 A.M. IST via Video Conferencing. The facility for remote e-voting will be available from Friday, July 17, 2026, at 09:00 A.M. IST to Sunday, July 19, 2026, at 05:00 P.M. IST. The cut-off date for determining eligibility to vote is Monday, July 13, 2026. MUFG Intime India Private Limited has been appointed to manage the e-voting process.

Key Dates

Event Date
Record Date for Dividend Friday, July 10, 2026
Cut-off Date for E-voting Monday, July 13, 2026
Remote E-voting Start Friday, July 17, 2026 at 09:00 A.M. IST
Remote E-voting End Sunday, July 19, 2026 at 05:00 P.M. IST
17th Annual General Meeting Monday, July 20, 2026 at 11:00 A.M. IST

The intimation was filed pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Parul Gupta, Company Secretary & Head - Legal, signed the communication on behalf of Rossari Biotech.

Historical Stock Returns for Rossari Biotech

1 Day5 Days1 Month6 Months1 Year5 Years
+1.13%+0.06%+1.67%-7.28%-25.62%-55.73%

How will the proposed dividend impact Rossari Biotech's free cash flow and capital allocation plans for FY2027?

What strategic growth initiatives or CAPEX plans does the management intend to highlight during the upcoming AGM?

Will the company provide guidance on margin expansion or new product launches for the upcoming financial year?

Rossari Biotech cuts Scope 1 emissions by 37.25% in FY26

2 min read     Updated on 29 Jun 2026, 08:51 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Rossari Biotech Limited reduced Scope 1 emissions by 37.25% in FY26 through lower diesel use, while improving energy and water intensity despite higher production volumes. The company recycled 778.14 metric tonnes of waste and maintained zero safety incidents, with full compliance on environmental regulations.

powered bylight_fuzz_icon
44292045

*this image is generated using AI for illustrative purposes only.

Rossari Biotech Limited achieved a 37.25% reduction in Scope 1 greenhouse gas (GHG) emissions during the financial year 2025-26, primarily driven by lower diesel consumption and enhanced fuel efficiency across operations. The specialty chemicals manufacturer reported progress in environmental performance metrics, including improved energy and water intensity, alongside expanded waste recycling efforts.

The company’s total energy consumption increased to 56,962.93 GigaJoules (GJ) in FY26 from 47,872.42 GJ in the previous year, attributed to higher production volumes. However, energy intensity improved to 0.556 GJ per metric tonne of aggregate (MTA) from 0.564 GJ/MTA, reflecting better operational efficiency. Renewable energy accounted for approximately 33% of total energy consumption during the year.

Water consumption rose to 1,31,406 kilolitres from 1,10,840 kilolitres, yet water intensity improved significantly to 1.08 KL/MTA from 1.55 KL/MTA. The company implemented water recycling initiatives, recovering approximately 1.665 KL of treated water for reuse. The Silvassa facility operates as a Zero Liquid Discharge (ZLD) unit.

Environmental Performance

Parameter FY 2025-26 FY 2024-25
Total Energy Consumption (GJ) 56,962.93 47,872.42
Energy Intensity (GJ/MTA) 0.556 0.564
Total Water Consumption (KL) 1,31,406 1,10,840
Water Intensity (KL/MTA) 1.08 1.55
Scope 1 Emissions (tCO2e) 1,402.99 2,235.68
Scope 2 Emissions (tCO2e) 3,854.13 2,983.26

Total waste generation increased to 3,401.35 metric tonnes from 1,696.55 metric tonnes, largely due to higher production volumes and increased hazardous waste streams. The company recycled approximately 778.14 metric tonnes of waste, including 387.57 metric tonnes of plastic waste and 246.96 metric tonnes of hazardous waste. Hazardous waste managed through pre-processing and co-processing methods increased to 246.96 metric tonnes from 45.44 metric tonnes in the previous year.

Governance and Compliance

The company reported no fines, penalties, or legal actions during the financial year. It maintained compliance with all applicable environmental regulations, including the Water Act, Air Act, and Environment Protection Act. Rossari Biotech’s Integrated Management System is certified to ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018 standards.

Mr. Edward Menezes, Executive Chairman, oversees the company’s sustainability agenda. The Board of Directors reviews performance against policies, while the Audit Committee monitors grievance redressal mechanisms. The company received a score of 93% in the Together for Sustainability audit and participated in the EcoVadis sustainability assessment.

Social and Employee Welfare

The company employed 600 employees and 678 workers as of March 31, 2026. Women comprised 17.33% of the total workforce and held 33.33% of Board positions. All employees and workers received training on health and safety measures, with 100% coverage for skill upgradation programs. The company reported zero safety incidents, including no lost time injuries or fatalities, during the year.

Historical Stock Returns for Rossari Biotech

1 Day5 Days1 Month6 Months1 Year5 Years
+1.13%+0.06%+1.67%-7.28%-25.62%-55.73%

What specific capital expenditures or technological upgrades are planned to further increase the renewable energy mix beyond the current 33%?

How will the company manage the rising trend in hazardous waste generation as production volumes continue to scale?

Does Rossari Biotech have a defined timeline or target for achieving carbon neutrality across Scope 1 and Scope 2 emissions?

More News on Rossari Biotech

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:-25.62%